Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China

World Journal of Gastroenterology

Volumn 9, Issue 12, 2003, Pages 2654-2657

  Zhang, Jian Hui ^a   Jin, Xia ^a   Li, Yan ^a   Wang, Rui ^a   Guo, Wei ^a   Wang, Na ^a   Wen, Deng Gui ^a   Chen, Zhi Feng ^a   Kuang, Gang ^a   Wei, Li Zhen ^a   Wang, Shi Jie ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; HISTIDINE; PRIMER DNA; TYROSINE;

ADULT; AGE; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SCREENING; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE MARKER; DISEASE PREDISPOSITION; ESOPHAGUS CARCINOMA; ESOPHAGUS TUMOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSOME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA;

EID: 9144233569     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i12.2654     Document Type: Article

References (24)

1. Yokokawa Y, Ohta S, Hou J, Zhang XL, Li SS, Ping YM, Nakajima T. Ecological study on the risks of esophageal cancer in Ci-Xian, China: The importance of nutritional status and the use of well water. Int J Cancer 1999; 83: 620-624
2. Launoy G, Milan CH, Faivre J, Pienkowski P, Milan CI, Gignoux M. Alcohol, tobacco and oesophageal cancer: Effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer 1997; 75: 1389-1396
3. Van Gijssel HE, Divi RL, Olivero OA, Roth MJ, Wang GQ, Dawsey SM, Albert PS, Qiao YL, Taylor PR, Dong ZW, Schrager JA, Kleiner DE, Poirier MC. Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system. Cancer Epidemiol Biomarkers Prev 2002; 11: 1622-1629
4. Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero OA, Poirier MC, Frye BL, Taylor PR, Weston A. Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett 2000; 156: 73-81
5. Omiecinski CJ, Aicher L, Swenson L. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 1994; 269: 417-423
6. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3: 421-428
7. Lee WJ, Brennan P, Boffetta P, London SJ, Benhamou S, Rannug A, To-Figueras J, Ingelman-Sundberg M, Shields P, Gaspari L, Taioli E. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: A quantitative review. Biomarkers 2002; 7: 230-241
8. Zhou W, Thurston SW, Liu G, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 461-466
9. Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, Wiseman RW, Taylor JA. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 1996; 17: 160-162
10. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 1999; 79: 168-171
11. Tiemersma EW, Omer RE, Bunschoten A, Van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2001; 10: 785-791
12. Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, Lee E, Zhu QS, Haile R, Levy D. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001; 61: 2381-2385
13. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, Tajima K. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001; 22: 913-916
14. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 551-556
15. Cai L, Yu SZ, Zhang ZF. Glutathione S-transferase M1, T1 genotypes and the risk of gastric cancer: A case-control study. World J Gastroenterol 2001; 7: 506-509
16. Cai L, Yu SZ, Zhang ZF. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. World J Gastroenterol 2001; 7: 792-795
17. Song C, Xing D, Tan W, Wei Q, Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272-3275
18. Zhang JH, Li Y, Wang R, Geddert H, Guo W, Wen DG, Chen ZF, Wei LZ, Kuang G, He M, Zhang LW, Wu ML, Wang SJ. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol 2003; 9: 1390-1393
19. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, Siegel D, Ross D, Gabbert HE, Sarbria M. Association of NAD(P)H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 2003; 24: 905-909
20. Amador AG, Righi PD, Radpour S, Everett ET, Weisberger E, Langer M, Eckert GJ, Christen AG, Campbell S Jr., Summerlin DJ, Reynolds N, Hartsfield JK Jr. Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 440-445
21. Lebailly P, Willett EV, Moorman AV, Roman E, Cartwright R, Morgan GJ, Wild CP. Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities. Br J Haematol 2002; 116: 587-594
22. Sierra-Torres CH, Au WW, Arrastia CD, Cajas-Salazar N, Robazetti SC, Payne DA, Tyring SK. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen 2003; 41: 69-76
23. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003; 27: 139-146
24. Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 2001; 33: 133-141